Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days
Clinical trial NCT00237445 · TERMINATED
Trial details
- NCT number
- NCT00237445
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2006-09-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.